Skip to main content
UHSUniversal Health Services, Inc.Sell5.8·$169.65+0.26%
SellModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5xImproving
  • Strong Earnings Beat With Analyst UpsideStable
  • Confirmed Downtrend Death Cross BlockImproving
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

SellValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $169.65 — A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$169.65+2.7% A.UpsideScore 5.8/10#13 of 35 Medical Care Facilities
QualityF-score8 / 9FCF yield4.98%
IncomeYield0.47%(5y avg 0.51%)Payout3.27%sustainable
Stop $160.27Target $174.28(analyst − 10%)A.R:R 0.5:1
Analyst target$193.65+14.1%17 analysts
$174.28our TP
$169.65price
$193.65mean
$290

Sell if holding. Analyst target reached at $169.65 — A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.8/10, moderate confidence.

Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Oct 26, 202651d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Attractive valuation
Margin of safety: 54%
Risks
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4)
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)6.9
P/E (Fwd)7.1
Mkt Cap$10.0B
EV/EBITDA5.7
Profit Mgn8.4%
ROE20.9%
Rev Growth8.3%
Beta1.06
Dividend0.47%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C8.42bearish
IV37%normal
Max Pain$160-5.7% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
1.3
Ma Position
3.0
Rsi
4.5
Obv
10.0
Volume accumulation (rising OBV)Below 200-MA, MA slope -3.4%/30d — confirmed downtrend
GatesMomentum 3.8<4.5A.R:R 0.5 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 51d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
49 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $164.71Resistance $179.73

Price Targets

$160
$174
A.Upside+2.7%
A.R:R0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (2.7% upside)
! News modifier -1: HOLD_IF_HOLDING → SELL_IF_HOLDING
! momentum at 3.8 (below the engine's 4.5 threshold)

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-10-26 (51d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Sell if holding. Analyst target reached at $169.65 — A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $160.27. Score 5.8/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $174.28 (+2.7% upside). Prior stop was $160.27. Stop-loss: $160.27.

What are the risks of investing in UHS?

Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Consecutive earnings misses (2).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 6.9 (forward 7.1). TrendMatrix value score: 8.0/10. Verdict: Sell.

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.4/5. Average price target: $194.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · ADUS (Addus HomeCare Corporation) · GRDN (Guardian Pharmacy Services, Inc)
Home Stocks UHS

Latest news

Latest News

Yahoo Finance45d agoEarnings
GuruFocus46d ago
Yahoo Finance136d ago
Yahoo Finance136d agoEarnings
TradingKey80d ago
AD HOC NEWS80d agoAnalyst
Sahm87d ago
Marketscreener.com46d ago
TipRanks46d ago
The Globe and Mail137d agoEarnings
TradingView137d agoEarnings
AD HOC NEWS81d agoEarnings
AD HOC NEWS82d ago
GuruFocus53d ago
Yahoo Finance53d ago
Smartkarma53d ago
Quiver Quantitative53d ago
Yahoo Finance88d ago
Newsline.com89d agoEarnings
TradingView44d agoEarnings
Loading more...